BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 17668070)

  • 21. Desferal inhibits breast tumor growth and does not interfere with the tumoricidal activity of doxorubicin.
    Hoke EM; Maylock CA; Shacter E
    Free Radic Biol Med; 2005 Aug; 39(3):403-11. PubMed ID: 15993339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of reactive oxygen species to ovarian cancer cell growth arrest and killing by the anti-malarial drug artesunate.
    Greenshields AL; Shepherd TG; Hoskin DW
    Mol Carcinog; 2017 Jan; 56(1):75-93. PubMed ID: 26878598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Artemisinin-derived dimer ART-838 potently inhibited human acute leukemias, persisted in vivo, and synergized with antileukemic drugs.
    Fox JM; Moynihan JR; Mott BT; Mazzone JR; Anders NM; Brown PA; Rudek MA; Liu JO; Arav-Boger R; Posner GH; Civin CI; Chen X
    Oncotarget; 2016 Feb; 7(6):7268-79. PubMed ID: 26771236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity.
    Shin SW; Seo CY; Han H; Han JY; Jeong JS; Kwak JY; Park JI
    Clin Cancer Res; 2009 Sep; 15(17):5414-25. PubMed ID: 19690198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-acetyl cysteine enhances imatinib-induced apoptosis of Bcr-Abl+ cells by endothelial nitric oxide synthase-mediated production of nitric oxide.
    Rakshit S; Bagchi J; Mandal L; Paul K; Ganguly D; Bhattacharjee S; Ghosh M; Biswas N; Chaudhuri U; Bandyopadhyay S
    Apoptosis; 2009 Mar; 14(3):298-308. PubMed ID: 19153832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HZ08, a great regulator to reverse multidrug resistance via cycle arrest and apoptosis sensitization in MCF-7/ADM.
    Cen J; Qi Y; Tao YF; Deng Y; Fang WR; Li YM; Zhang LY; Huang WL
    Eur J Pharmacol; 2010 Nov; 647(1-3):21-30. PubMed ID: 20816813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VCPA, a novel synthetic derivative of α-tocopheryl succinate, sensitizes human gastric cancer to doxorubicin-induced apoptosis via ROS-dependent mitochondrial dysfunction.
    Wu H; Liu S; Gong J; Liu J; Zhang Q; Leng X; Zhang N; Li Y
    Cancer Lett; 2017 May; 393():22-32. PubMed ID: 28216375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
    Roh JL; Kim EH; Jang H; Shin D
    Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of CD95 ligand and apoptosis by doxorubicin is modulated by the redox state in chemosensitive- and drug-resistant tumor cells.
    Friesen C; Fulda S; Debatin KM
    Cell Death Differ; 1999 May; 6(5):471-80. PubMed ID: 10381639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of stable inhibition of NRF2 on doxorubicin sensitivity in human ovarian carcinoma OV90 cells.
    Manandhar S; Lee S; Kwak MK
    Arch Pharm Res; 2010 May; 33(5):717-26. PubMed ID: 20512470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 18beta-Glycyrrhetinic acid induces apoptotic cell death in SiHa cells and exhibits a synergistic effect against antibiotic anti-cancer drug toxicity.
    Lee CS; Kim YJ; Lee MS; Han ES; Lee SJ
    Life Sci; 2008 Sep; 83(13-14):481-9. PubMed ID: 18721818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aclarubicin-induced ROS generation and collapse of mitochondrial membrane potential in human cancer cell lines.
    Rogalska A; Koceva-Chyła A; Jóźwiak Z
    Chem Biol Interact; 2008 Oct; 176(1):58-70. PubMed ID: 18692031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Artesunate exerts specific cytotoxicity in retinoblastoma cells via CD71.
    Zhao F; Wang H; Kunda P; Chen X; Liu QL; Liu T
    Oncol Rep; 2013 Sep; 30(3):1473-82. PubMed ID: 23818062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel compound modified from tanshinone inhibits tumor growth in vivo via activation of the intrinsic apoptotic pathway.
    Tian HL; Yu T; Xu NN; Feng C; Zhou LY; Luo HW; Chang DC; Le XF; Luo KQ
    Cancer Lett; 2010 Nov; 297(1):18-30. PubMed ID: 20494511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-treatment with the anti-malarial drugs mefloquine and primaquine highly sensitizes drug-resistant cancer cells by increasing P-gp inhibition.
    Kim JH; Choi AR; Kim YK; Yoon S
    Biochem Biophys Res Commun; 2013 Nov; 441(3):655-60. PubMed ID: 24284282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An in vitro and in vivo study of a novel zinc complex, zinc N-(2-hydroxyacetophenone)glycinate to overcome multidrug resistance in cancer.
    Ghosh RD; Das S; Ganguly A; Banerjee K; Chakraborty P; Sarkar A; Chatterjee M; Nanda A; Pradhan K; Choudhuri SK
    Dalton Trans; 2011 Nov; 40(41):10873-84. PubMed ID: 21717020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alantolactone induces apoptosis in glioblastoma cells via GSH depletion, ROS generation, and mitochondrial dysfunction.
    Khan M; Yi F; Rasul A; Li T; Wang N; Gao H; Gao R; Ma T
    IUBMB Life; 2012 Sep; 64(9):783-94. PubMed ID: 22837216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
    Mizutani Y; Yoshida O; Bonavida B
    J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Artesunate induces ROS- and p38 MAPK-mediated apoptosis and counteracts tumor growth in vivo in embryonal rhabdomyosarcoma cells.
    Beccafico S; Morozzi G; Marchetti MC; Riccardi C; Sidoni A; Donato R; Sorci G
    Carcinogenesis; 2015 Sep; 36(9):1071-83. PubMed ID: 26153023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of doxorubicin-transferrin conjugate in apoptosis induction in human leukemia cells through reactive oxygen species generation.
    Szwed M; Laroche-Clary A; Robert J; Jozwiak Z
    Cell Oncol (Dordr); 2016 Apr; 39(2):107-18. PubMed ID: 26611752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.